This company listing is no longer active
Global Blood Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Key information
491.7%
Debt to equity ratio
US$581.95m
Debt
Interest coverage ratio | n/a |
Cash | US$517.16m |
Equity | US$118.36m |
Total liabilities | US$752.08m |
Total assets | US$870.44m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0IVZ's short term assets ($640.0M) exceed its short term liabilities ($93.1M).
Long Term Liabilities: 0IVZ's short term assets ($640.0M) do not cover its long term liabilities ($659.0M).
Debt to Equity History and Analysis
Debt Level: 0IVZ's net debt to equity ratio (54.7%) is considered high.
Reducing Debt: Insufficient data to determine if 0IVZ's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0IVZ has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0IVZ has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.